Through friends http://barlens.com.au/aps-igf-1-extreme-reviews-72f7.pdf#hobble aps igf 1 extreme
  The company said a separate trial, testing ramucirumab as a treatment for advanced gastric cancer, met the main goal of improving patients' survival. It was the second stomach cancer trial that showed the drug improved survival.